From ‘Who We Are’ on RemedyPartners.com Our Core Value: Empathy
CMS Embraces Innovation and Competition
Steve Wiggins with Nick Bluhm and Ryan PardoSeptember 20, 2017
Today, Seema Verma, the Centers for Medicare and Medicaid Services (CMS) Administrator, published a Request for Information seeking feedback on how to lead CMS’s Innovation Center in a new direction. Her statements reflect a belief in competition, consumer empowerment and a willingness to use waivers to enable meaningful innovation.
Remedy in the News
Remedy continues to be a strong advocate for the BPCI program and using bundled payment models as a path to healthcare transformation.>
CMS proposes changes to CJR: 6 key thoughts on what this means for orthopedic bundled payments
Becker's Spine Review | August 18, 2017
Is HHS’ Proposal to Scale Back Mandatory Bundled Payments a Step Back from Value-Based Care? Many Healthcare Experts Say No
Healthcare Informatics | August 18, 2017
Chris Garcia Named CEO of Remedy Partners
Remedy Partners, the nation’s leading bundled payment company, has named Chris Garcia its chief executive officer, effective July 12, 2017. Remedy is well-positioned for accelerated growth as the healthcare industry continues to adopt bundled payments as a core value-based payment strategy.
The two orthopaedic faculty presenting at Remedy’s October 2015 Innovation Collaborative are successful participants in BPCI’s total joint replacement (TJR) bundle. Rob Krushell MD, from New England Orthopedic Surgeons and Medical Director for Hip and Knee Replacement at Baystate Medical Center, Springfield, MA has been working in bundled payments since 2011, first with a commercial health plan and then as a BPCI participant. Jeff Malumed MD, Chair of Orthopaedics at Taylor Hospital, Ridley Park, PA, and President of Premier Orthopaedics and Sports Medicine Associates, has participated in the BPCI program as an Episode Initiator with Remedy Partners as Convener since July 2015.
SNF Readmission and Mortality Risk Versus Discharges to Home
Co-Authored by Steve Wiggins, Brittain Brantley, Mary Dittrich, MD, Marina Burke, NP, Win Whitcomb, MD
Evidence is growing that patients fare comparatively well when choosing to go home after a hospitalization, versus being admitted to a post acute facility. Patients discharged to
their homes have readmission and mortality risk that is equivalent and possibly lower than patients with similar conditions who are discharged to skilled nursing facilities (SNFs) or other post acute facilities. Remedy’s own research, as well as studies published by the American Heart Association and the American Journal of Medicine, provides encouraging evidence to support discharges to home for challenging patients.